Free Trial
NASDAQ:MDRX

Veradigm (MDRX) Stock Price, News & Analysis

Veradigm logo
$4.94 -0.01 (-0.20%)
As of 01:46 PM Eastern

About Veradigm Stock (NASDAQ:MDRX)

Key Stats

Today's Range
$4.50
$4.94
50-Day Range
$4.21
$5.05
52-Week Range
$3.00
$11.80
Volume
385 shs
Average Volume
265,572 shs
Market Capitalization
$534.83 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$13.00
Consensus Rating
Hold

Company Overview

Veradigm Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
52nd Percentile Overall Score

MDRX MarketRank™: 

Veradigm scored higher than 52% of companies evaluated by MarketBeat, and ranked 155th out of 304 stocks in the business services sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Veradigm has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no buy ratings, 1 hold rating, and no sell ratings.

  • Amount of Analyst Coverage

    Veradigm has received no research coverage in the past 90 days.

  • Read more about Veradigm's stock forecast and price target.
    • Short Interest

      There is no current short interest data available for MDRX.
    • Dividend Yield

      Veradigm does not currently pay a dividend.

    • Dividend Growth

      Veradigm does not have a long track record of dividend growth.

    • Short Interest

      There is no current short interest data available for MDRX.
    • News Sentiment

      Veradigm has a news sentiment score of 0.03. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 1.00 average news sentiment score of Business Services companies.
    • News Coverage This Week

      MarketBeat has tracked 4 news articles for Veradigm this week, compared to 2 articles on an average week.
    • Search Interest

      Only 2 people have searched for MDRX on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days.
    Receive MDRX Stock News and Ratings via Email

    Sign-up to receive the latest news and ratings for Veradigm and its competitors with MarketBeat's FREE daily newsletter.

    By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

    MDRX Stock News Headlines

    Veradigm Amends and Extends Stockholder Rights Plan
    Veradigm Appoints Donald Trigg as New CEO
    Trump’s national nightmare is here
    Porter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger the biggest forced rotation of capital since World War II. They reveal why Trump is mobilizing America’s tech giants… and name the two stocks most likely to soar as trillions shift behind the scenes.tc pixel
    Veradigm Appoints Don Trigg as Chief Executive Officer
    Veradigm Inc. Delays Q2 2025 Financial Report
    Veradigm Provides 2025 Financial & Business Update
    See More Headlines

    MDRX Stock Analysis - Frequently Asked Questions

    Veradigm's stock was trading at $9.75 on January 1st, 2025. Since then, MDRX stock has decreased by 49.2% and is now trading at $4.95.

    Veradigm Inc. (NASDAQ:MDRX) issued its quarterly earnings data on Thursday, November, 4th. The software maker reported $0.27 earnings per share for the quarter, beating the consensus estimate of $0.18 by $0.09. Veradigm's quarterly revenue was down 8.2% on a year-over-year basis.

    The following companies are subsidiaries of Veradigm: ZappRx, HealthGrid, and Practice Fusion.

    Shares of MDRX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

    Based on aggregate information from My MarketBeat watchlists, some other companies that Veradigm investors own include NVIDIA (NVDA), Meta Platforms (META), Broadcom (AVGO), Advanced Micro Devices (AMD), Adobe (ADBE), GE Aerospace (GE) and ServiceNow (NOW).

    Company Calendar

    Last Earnings
    11/04/2021
    Today
    8/27/2025
    Fiscal Year End
    12/31/2025

    Industry, Sector and Symbol

    Stock Exchange
    NASDAQ
    Industry
    Computer integrated systems design
    Sub-Industry
    Health Care Technology
    Current Symbol
    NASDAQ:MDRX
    CIK
    1124804
    Employees
    8,000
    Year Founded
    1986

    Price Target and Rating

    High Price Target
    $13.00
    Low Price Target
    $13.00
    Potential Upside/Downside
    +162.6%
    Consensus Rating
    Hold
    Rating Score (0-4)
    2.00
    Research Coverage
    1 Analysts

    Profitability

    EPS (Trailing Twelve Months)
    N/A
    Trailing P/E Ratio
    N/A
    Forward P/E Ratio
    N/A
    P/E Growth
    N/A
    Net Income
    N/A
    Net Margins
    N/A
    Pretax Margin
    N/A
    Return on Equity
    N/A
    Return on Assets
    N/A

    Debt

    Debt-to-Equity Ratio
    N/A
    Current Ratio
    N/A
    Quick Ratio
    N/A

    Sales & Book Value

    Annual Sales
    $1.53 billion
    Price / Sales
    0.35
    Cash Flow
    N/A
    Price / Cash Flow
    N/A
    Book Value
    N/A
    Price / Book
    N/A

    Miscellaneous

    Outstanding Shares
    108,265,000
    Free Float
    105,175,000
    Market Cap
    $535.91 million
    Optionable
    No Data
    Beta
    0.69

    Social Links

    Reduce the Risk Cover

    Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

    Get This Free Report

    This page (NASDAQ:MDRX) was last updated on 8/27/2025 by MarketBeat.com Staff
    From Our Partners